Related Experiment Video
Updated: Feb 13, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells
Abstract:
Increasing evidence has shown that the dysregulation of microRNAs (miRNAs) is associated with drug resistance. Fulvestrant and tamoxifen represent the major endocrine drugs for the treatment of breast cancer patients, and yet little is known about the biological mechanisms of acquiring resistance to fulvestrant and tamoxifen, let alone the differences between cell lines resistant to these two drugs. Exploration of the differential miRNA profiles between these two cell lines is a useful way to further clarify these resistance mechanisms. The fulvestrant-resistant cell line (MCF7-F) and the tamoxifen-resistant cell line (MCF7-T) were established from the drug-sensitive parental MCF7 cell line using a 21-day high-dose antiestrogen induction method. Differentially expressed miRNA profiles of MCF7-F and MCF7-T were detected using microarray; then, multiple bioinformatic analyses were carried out, including protein-protein interaction network, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes pathway analysis. Compared with the parental MCF7 cell line, more miRNAs were found to be participating in the process of acquiring fulvestrant resistance than tamoxifen resistance. miR-4532, miR-486-5p, miR-138, miR-1228, and miR-3178 could be new targets for combating both fulvestrant resistance and tamoxifen resistance. miR-3188, miR-21, miR-149, and others may be associated with fulvestrant resistance, whereas miR-342 and miR-1226 may be associated with tamoxifen resistance in breast cancer cells. We found differential miRNA profiles between fulvestrant-resistant and tamoxifen-resistant breast cancer cells, but the definite mechanism involved in gaining resistance still needs further study.
Insights
Investigating microRNA (miRNA) profiles in breast cancer cells reveals distinct patterns associated with resistance to fulvestrant and tamoxifen. Certain miRNAs show potential as therapeutic targets against both drug resistances.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Drug resistance in breast cancer, particularly to endocrine therapies like fulvestrant and tamoxifen, is a significant clinical challenge.
- The underlying biological mechanisms of resistance to these drugs, and their differences, remain incompletely understood.
- MicroRNAs (miRNAs) are increasingly recognized as key regulators involved in drug resistance.
Purpose of the Study:
- To explore and compare the differential miRNA expression profiles in breast cancer cell lines resistant to fulvestrant versus tamoxifen.
- To identify potential miRNA biomarkers and therapeutic targets for overcoming endocrine resistance in breast cancer.
Main Methods:
- Established fulvestrant-resistant (MCF7-F) and tamoxifen-resistant (MCF7-T) cell lines from the parental MCF7 cell line via high-dose antiestrogen induction.
- Utilized microarray analysis to detect differentially expressed miRNAs between resistant and sensitive cell lines.
- Performed bioinformatic analyses, including protein-protein interaction networks, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes pathway analysis.
Main Results:
- More miRNAs were implicated in the development of fulvestrant resistance compared to tamoxifen resistance.
- Identified five miRNAs (miR-4532, miR-486-5p, miR-138, miR-1228, miR-3178) as potential targets for combating both fulvestrant and tamoxifen resistance.
- Associated specific miRNAs with fulvestrant resistance (e.g., miR-3188, miR-21, miR-149) and tamoxifen resistance (e.g., miR-342, miR-1226).
Conclusions:
- Demonstrated distinct miRNA profiles between fulvestrant-resistant and tamoxifen-resistant breast cancer cells.
- Highlighted specific miRNAs as potential therapeutic targets for overcoming endocrine resistance.
- Emphasized the need for further research to elucidate the precise mechanisms of acquired drug resistance.
More Related Videos
06:02Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...